Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells

Toxicology in Vitro

Volumn 30, Issue 1, 2015, Pages 348-354

  Ponce Ruiz, N ^a   Rojas Garcia A E ^a   Barron Vivanco B S ^a   Elizondo, G ^b   Bernal Hernandez Y Y ^a   Mejia Garcia A ^b   Medina Diaz I M ^a  

^a UNIVERSIDAD AUTÓNOMA DE NAYARIT   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

HepG2 cell; Nuclear receptors; Paraoxonase 1; Transcription

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARYLDIALKYLPHOSPHATASE 1; CELL NUCLEUS RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNENOLONE; RETINOIC ACID; RIFAMPICIN; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; CYP1A1 GENE; CYP3A4 GENE; DNA BINDING; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; PON1 GENE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; GENETICS; HEP-G2 CELL LINE; PHYSIOLOGY;

ARYLDIALKYLPHOSPHATASE; DEXAMETHASONE; GLUCOCORTICOIDS; HEP G2 CELLS; HUMANS; PREGNENOLONE; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84958657064     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.09.031     Document Type: Article

References (33)

1. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 1998, 101:1581-1590.
2. Camps J., Garcia-Heredia A., Rull A., Alonso-Villaverde C., Aragones G., Beltrán-Debón R., Rodríguez-Gallegos E., Joven J. PPARs in regulation of paraoxonases: control of oxidative stress and inflammation pathway. PPAR Res. 2011, 2012:1-10.
3. Costa L.G., Giordano G., Furlong C.E. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem. Pharmacol. 2011, 81:337-344.
4. Coumoul X., Diry M., Barouki R. PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem. Pharmacol. 2002, 64:1513-1519.
5. Deakin S., Leviev I., Gomaraschi M., Calabresi L., Franceschini G., James R.W. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high-affinity, saturable, desorption mechanism. J. Biol. Chem. 2001, 277:4301-4308.
6. Dussault I., Lin M., Hollister K., Wang E.H., Synold T.W., Forman B.M. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J. Biol. Chem. 2001, 276:33309-33312.
7. Fuhrman B. Regulation of hepatic paraoxonase-1 expression. J. Lipids 2012, 1-5.
8. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 2001, 276:14581-14587.
9. Gouédard C., Koum-Besson N., Barouki R., Morel Y. Opposite regulation of the human paraoxonase-1 gene PON1 by fenofibrate and statins. Mol. Pharmacol. 2003, 63:945-956.
10. Gouédard C., Barouki R., Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cel. Biol. 2004, 24:5209-5222.
11. Guyot E., Coumoul X., Chasse J.F., Khallouki F., Savouret J.F., Poirot M., Barouki R. Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the aryl hydrocarbon receptor. Biochem. Pharmacol. 2011, 83:627-632.
12. Ikeda Y., Suehiro T., Arii K., Kumon Y., Hashimoto K. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes. Metabolism 2008, 57:1725-1732.
13. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., Tontonoz P., Kliewer S., Willson T.M., Edwards P.A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, Farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 2002, 277:2908-2915.
14. Khateeb J., Gantman A., Kreitenberg A.J., Aviram M., Fuhrman B. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-γ pathway. Atherosclerosis 2010, 208:119-125.
15. Lemaire G., de Sousa G., Rahmani R. A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. Biochem. Pharmacol. 2004, 68:2347-2358.
16. -ΔΔC(T) method. Methods 2001, 25:402-408.
17. Luckert C., Ehlers A., Buhrke T., Seidel A., Lampen A., Hessel S. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR. Toxicol. Lett. 2013, 222:180-188.
18. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991, 286:152-154.
19. Mackness B., Beltran-Debon R., Aragones G., Joven J., Camps J., Mackness M. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 2010, 62:480-482.
20. Marsillach J., Camps J., Ferré N., Beltran R., Rull A., Mackness B., Mackness M., Joven J. Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol. 2009, 9:1-13.
21. Martínez C., Molina J.A., Alonso-Navarro H., Jiménez-Jiménez F.J., Agundez J.A.G., García-Martín E. Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol. 2010, 10:1-7.
22. Matsunaga T., Maruyama M., Matsubara T., Nagata K., Yamazoe Y., Ohmori S. Mechanism of CYP3A4 induction by glucocorticoids in human fetal liver cells. Drug Metab. Pharmacokinet. 2012, 27:653-657.
23. Medina-Díaz I.M., Arteaga-Illán G., Bermudez de León M., Cisneros B., Sierra-Santoyo A., Vega L., Gonzalez F.J., Elizondo G. Pregnane X receptor-dependent induction of the CYP3A4 gene by o,p'-1,1,1,-trichloro-2,2-bis (p-chlorophenyl) ethane. Drug Metab. Dispos. 2006, 35:95-102.
24. Orans J., Teotico D.G., Redinbo M.R. The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. Mol. Endocrinol. 2005, 19:2891-2900.
25. Ota K., Suehiro T., Arii K., Ikeda Y., Kumon Y., Osaki F., Hashimoto K. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. Metabolism 2005, 54:142-150.
26. Pascussi J.M., Drocourt L., Fabre J.M., Maurel P., Vilarem M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 2000, 58:361-372.
27. Pascussi J.M., Drocourt L., Gerbal-Chaloin S., Fabre J.M., Maurel P., Vilarem M.J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Eur. J. Biochem. 2001, 268:6346-6357.
28. Précourt L.P., Amre D., Denis M.C., Lavoie J.C., Delvin E., Seidman E., Levy E. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011, 214:20-36.
29. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33:498-507.
30. Schrader C., Rimbach G. Determinants of paraoxonase 1 status: genes, drugs and nutrition. Curr. Med. Chem. 2011, 18:5624-5643.
31. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., Liu Y., Klaassen C.D., Brown K.K., Reinhard J., Willson T.M., Koller B.H., Kliewer S.A. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3369-3374.
32. Synold T.W., Dussault I., Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 2001, 7:584-590.
33. Ticozzi N., LeClerc A.L., Keagle P., Glass J.D., Wills A.M., Blitterswijk M.V., Bosco D.A., Rodriguez L.I., Gellera C., Ratti A., Taroni F., Mckenna-Yasek D.M., Sapp P.C., Silani V., Furlong C.E., Brown R.H., Landers J.E. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann. Neurol. 2010, 68(1):102-107.